Letrozol i fertilitetsbehandling

Emilie Steentoft Dahlberg; Dorte Andersen; Pernilla Skjødt Andersson; Kathrine Birch; Lotte Colmon; Marianne Dreyer Holt; Kasper Ingerslev; Kirstine Kirkegaard; Kristine Løssl; Liv la Cour Poulsen; Marie-Louise Wissing; Mathilde Yde; Nathalie Søderhamn Bülow

Letrozol i fertilitetsbehandling

Translated title of the contribution: Not Available

Emilie Steentoft Dahlberg, Dorte Andersen, Pernilla Skjødt Andersson, Kathrine Birch, Lotte Colmon, Marianne Dreyer Holt, Kasper Ingerslev, Kirstine Kirkegaard, Kristine Løssl, Liv la Cour Poulsen, Marie-Louise Wissing, Mathilde Yde, Nathalie Søderhamn Bülow

Department of Clinical Medicine - Kvindesygdomme og Fødsler, Horsens

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

4 Downloads (Pure)

Abstract

This review describes the current evidence regarding the putative indications of letrozole (LTZ) in fertility treatment. Prior to intrauterine insemination, LTZ is recommended in women with normogonadotrophic oligo-anovulation. In ovulatory women, LTZ is equal to clomiphene and may be used instead of exogenous gonadotrophin. LTZ may be used as co-treatment in poor responders prior to in vitro fertilization/intracytoplasmic sperm injection. In addition, LTZ prior to frozen-thawed embryo transfer is increasingly used in women with normogonadotrophic oligo-anovulation.

Translated title of the contribution	Not Available
Original language	Danish
Article number	V05230315
Journal	Ugeskrift for Læger
Volume	185
Issue	41
Number of pages	8
ISSN	0041-5782
Publication status	Published - Oct 2023

Access to Document

Letrozol i fertilitetsbehandlingFinal published version, 800 KBLicence: CC BY-NC-ND

Cite this

@article{ae080380a8364f9e846495c4e447c413,

title = "Letrozol i fertilitetsbehandling",

abstract = "This review describes the current evidence regarding the putative indications of letrozole (LTZ) in fertility treatment. Prior to intrauterine insemination, LTZ is recommended in women with normogonadotrophic oligo-anovulation. In ovulatory women, LTZ is equal to clomiphene and may be used instead of exogenous gonadotrophin. LTZ may be used as co-treatment in poor responders prior to in vitro fertilization/intracytoplasmic sperm injection. In addition, LTZ prior to frozen-thawed embryo transfer is increasingly used in women with normogonadotrophic oligo-anovulation.",

author = "Dahlberg, {Emilie Steentoft} and Dorte Andersen and Andersson, {Pernilla Skj{\o}dt} and Kathrine Birch and Lotte Colmon and Holt, {Marianne Dreyer} and Kasper Ingerslev and Kirstine Kirkegaard and Kristine L{\o}ssl and Poulsen, {Liv la Cour} and Marie-Louise Wissing and Mathilde Yde and B{\"u}low, {Nathalie S{\o}derhamn}",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2023",

month = oct,

language = "Dansk",

volume = "185",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "41",

}

TY - JOUR

T1 - Letrozol i fertilitetsbehandling

AU - Dahlberg, Emilie Steentoft

AU - Andersen, Dorte

AU - Andersson, Pernilla Skjødt

AU - Birch, Kathrine

AU - Colmon, Lotte

AU - Holt, Marianne Dreyer

AU - Ingerslev, Kasper

AU - Kirkegaard, Kirstine

AU - Løssl, Kristine

AU - Poulsen, Liv la Cour

AU - Wissing, Marie-Louise

AU - Yde, Mathilde

AU - Bülow, Nathalie Søderhamn

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2023/10

Y1 - 2023/10

N2 - This review describes the current evidence regarding the putative indications of letrozole (LTZ) in fertility treatment. Prior to intrauterine insemination, LTZ is recommended in women with normogonadotrophic oligo-anovulation. In ovulatory women, LTZ is equal to clomiphene and may be used instead of exogenous gonadotrophin. LTZ may be used as co-treatment in poor responders prior to in vitro fertilization/intracytoplasmic sperm injection. In addition, LTZ prior to frozen-thawed embryo transfer is increasingly used in women with normogonadotrophic oligo-anovulation.

AB - This review describes the current evidence regarding the putative indications of letrozole (LTZ) in fertility treatment. Prior to intrauterine insemination, LTZ is recommended in women with normogonadotrophic oligo-anovulation. In ovulatory women, LTZ is equal to clomiphene and may be used instead of exogenous gonadotrophin. LTZ may be used as co-treatment in poor responders prior to in vitro fertilization/intracytoplasmic sperm injection. In addition, LTZ prior to frozen-thawed embryo transfer is increasingly used in women with normogonadotrophic oligo-anovulation.

UR - http://www.scopus.com/inward/record.url?scp=85175661694&partnerID=8YFLogxK

M3 - Tidsskriftartikel

C2 - 37873987

SN - 0041-5782

VL - 185

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 41

M1 - V05230315

ER -

Letrozol i fertilitetsbehandling

Abstract

Access to Document

Other files and links

Fingerprint

Cite this